These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11815995)

  • 21. Malignant phyllodes tumours of the breast display increased stromal p53 protein expression.
    Millar EK; Beretov J; Marr P; Sarris M; Clarke RA; Kearsley JH; Lee CS
    Histopathology; 1999 Jun; 34(6):491-6. PubMed ID: 10383692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phyllodes tumor (cystosarcoma phyllodes) of the breast. A clinicopathologic study of 45 cases.
    Inoshita S
    Acta Pathol Jpn; 1988 Jan; 38(1):21-33. PubMed ID: 2834912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors.
    Barth RJ
    Breast Cancer Res Treat; 1999 Oct; 57(3):291-5. PubMed ID: 10617306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
    Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
    Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressive deregulation of the cell cycle with higher tumor grade in the stroma of breast phyllodes tumors.
    Kuijper A; de Vos RA; Lagendijk JH; van der Wall E; van Diest PJ
    Am J Clin Pathol; 2005 May; 123(5):690-8. PubMed ID: 15981808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased p53 protein expression in malignant mammary phyllodes tumors.
    Tse GM; Putti TC; Kung FY; Scolyer RA; Law BK; Lau TS; Lee CS
    Mod Pathol; 2002 Jul; 15(7):734-40. PubMed ID: 12118111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 protein expression and gene mutation in phyllodes tumors of the breast.
    Gatalica Z; Finkelstein S; Lucio E; Tawfik O; Palazzo J; Hightower B; Eyzaguirre E
    Pathol Res Pract; 2001; 197(3):183-7. PubMed ID: 11314782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression.
    Zhang Y; Liss AL; Chung E; Pierce LJ; Kleer CG
    Breast Cancer Res Treat; 2016 Jul; 158(1):21-28. PubMed ID: 27290698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 and c-erbB-2 but not bcl-2 are predictive of metastasis-free survival in breast cancer patients receiving post-mastectomy adjuvant radiotherapy in Taiwan.
    Chen HH; Su WC; Guo HR; Chang TW; Lee WY
    Jpn J Clin Oncol; 2002 Sep; 32(9):332-9. PubMed ID: 12417598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic Characteristics and Patient Outcomes of Phyllodes Tumors: A Single Institution Experience.
    Mohan SC; Tseng J; Angarita S; Marumoto A; Dadmanesh F; Amersi F; Giuliano A; Chung A
    Am Surg; 2021 Dec; 87(10):1533-1538. PubMed ID: 34689588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome.
    Onkendi EO; Jimenez RE; Spears GM; Harmsen WS; Ballman KV; Hieken TJ
    Ann Surg Oncol; 2014 Oct; 21(10):3304-9. PubMed ID: 25034817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD10, actin, and vimentin expression in breast phyllodes tumors correlates with tumor grades of the WHO grading system.
    Tsai WC; Jin JS; Yu JC; Sheu LF
    Int J Surg Pathol; 2006 Apr; 14(2):127-31. PubMed ID: 16703173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast.
    Barrio AV; Clark BD; Goldberg JI; Hoque LW; Bernik SF; Flynn LW; Susnik B; Giri D; Polo K; Patil S; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2961-70. PubMed ID: 17562113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Overexpression of c-erbB-2 and p53 oncoprotein in renal pelvic and ureteral carcinomas with reference to the expression of Ki-67 antigen as a proliferation marker].
    Hashimoto H; Sue Y; Tokumitsu M; Saga Y; Yachiku S
    Nihon Hinyokika Gakkai Zasshi; 1997 Jun; 88(6):605-11. PubMed ID: 9234617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical expression of heparan sulfate correlates with stromal cell proliferation in breast phyllodes tumors.
    Koo CY; Bay BH; Lui PC; Tse GM; Tan PH; Yip GW
    Mod Pathol; 2006 Oct; 19(10):1344-50. PubMed ID: 16862076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2005 Galloway Memorial Lecture: Breast phyllodes tumours--morphology and beyond.
    Tan PH
    Ann Acad Med Singap; 2005 Dec; 34(11):671-7. PubMed ID: 16453039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In phyllodes tumour of the breast expression of c-kit but not of ALDH1A1 is associated with adverse clinico-pathological features.
    Chougule A; Bal A; Das A; Kohli PS; Singh G
    Virchows Arch; 2016 Dec; 469(6):651-658. PubMed ID: 27696244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of Ki-67, CD10, CD34, p53, CD117, and mast cell content in the differential diagnosis of cellular fibroadenomas and in the classification of phyllodes tumors of the breast.
    Vilela MH; de Almeida FM; de Paula GM; Ribeiro NB; Cirqueira MB; Silva AL; Moreira MA
    Int J Surg Pathol; 2014 Sep; 22(6):485-91. PubMed ID: 24492332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phyllodes tumor of the breast: EGFR family expression and relation to clinicopathological features.
    Suo Z; Nesland JM
    Ultrastruct Pathol; 2000; 24(6):371-81. PubMed ID: 11206334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.